From Surf Wiki (app.surf) — the open knowledge base
MiraDry
Microwave-based medical device used to treat axillary hyperhydrosis
Microwave-based medical device used to treat axillary hyperhydrosis
miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis. It was approved by the US Food and Drug Administration (FDA) in 2011 and was also approved in Europe. miraDry selectively destroys axillary sweat glands without affecting the superficial layers of the skin. In addition to sweat glands, miraDry destroys hair follicles in the axillary region regardless of hair color. It is about 72.5 to 90% effective and sweat is reduced by about 82% on average. It also reduces axillary hair by about 75%. The effects of miraDry are noticeable almost immediately and are long-lasting or permanent. A case of death due to miraDry caused by necrotizing fasciitis that was complicated by streptococcal toxic shock syndrome has been reported.
References
References
- (November 2022). "Potential use of microwave technology in dermatology". J Dermatolog Treat.
- (January 2022). "Treatment of Axillary hyperhidrosis". J Cosmet Dermatol.
- (March 2013). "Treatment of hyperhidrosis with microwave technology". Semin Cutan Med Surg.
- "Home - miraDry".
- (March 2024). "New developments in cosmetic applications of electromagnetic fields: Client and occupational hazard assessment". Bioelectromagnetics.
- (September 2022). "Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome". Leg Med (Tokyo).
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about MiraDry — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report